BST is part of CERTERA: Consortium for the development of advanced therapy medicines
Principal Investigator
Joaquim Delgadillo Duarte
File
CERT22/00001
Duration
2024 – 2026
Funded by
Carlos III Institute of Health and by the European Union "NextGenerationEU" and the Recovery, Transformation and Resilience Plan
Objective
To create a networked R&D&I innovation hub for advanced therapy medicines through a consortium model, sponsored by the Ministry of Science and Innovation, under the leadership of the Carlos III Health Institute.